前列舒宁胶囊治疗慢性前列腺炎的临床疗效观察  

Efficacy Observation of Qianlie Shuning Capsule in the Treatment of Chronic Prostatitis

作　　者：汪皓[1] 张凯麟[1] 

机构地区：[1]天水市第一人民医院,甘肃天水741000

出　　处：《中国药房》2013年第27期2569-2571,共3页China Pharmacy

摘　　要：目的:观察前列舒宁胶囊治疗慢性前列腺炎的临床疗效。方法:120例患者随机分为试验组和对照组。试验组80例患者服用前列舒宁胶囊,每次4粒,每天3次;对照组40例患者服用前列通瘀胶囊,每次5粒,每天3次。1月为1个疗程,连续2个疗程,并坚持随访1月。观察治疗前后患者临床症状及前列腺液白细胞(EPS-WBC)数、EPS-卵磷脂小体数、慢性前列腺炎症状积分指数(NIH-CPSI)各项评分的变化。结果:与治疗前比较,治疗后试验组与对照组患者EPS-WBC数显著降低、EPS-卵磷脂小体数显著升高、NIH-CPSI各项评分显著升高;与对照组比较,试验组患者上述指标改善更明显,总有效率显著升高,中医分型情况显著改善(P<0.05)。未发现有任何不良反应。结论:前列舒宁胶囊治疗慢性前列腺炎的疗效较好,患者具有较好的依从性。OBJECTIVE： To observe the clinical efficacy of Qianlie shuning capsule in the treatment of chronic prostatitis. METHODS： 120 cases were randomly divided into trial group and control group. 80 patients in trial group were treated with Qianlie shuning capsule, 3 times a day, 4 pills each times; 40 cases in control group were treated with Qianlie tongyu capsules, 3 times a day, 5 pills each times. A treatment course lasted for a month, and they received 2 courses and followed-up for a month. The clinical symptoms and the score of EPS-WBC, the number of the EPS-lecithin, the NIH-CPSI were observed before and after treatment. RESULTS： Compared with before treatment, the score of EPS-WBC in trial group and control group were decreased significantly, while the number of EPS-lecithin and NIH-CPSI were increased significantly. Compared with control group, above index of trial group were improved more significantly, and total effective rate was increased significantly,and TCM type was better （P0.05）; no adverse drug reaction was found. CONCLUSIONS： Qianlie shuning capsule is superior to traditional drugs for chronic prostatitis with sound compliance.

关 键 词：前列舒宁胶囊 慢性前列腺炎 临床疗效 

分 类 号：R472[医药卫生—护理学] R969[医药卫生—临床医学]